Bernstein Liebhard LLP Announces Investigation of Adolor Corporation
October 24 2011 - 10:36AM
Business Wire
Bernstein Liebhard LLP is investigating whether the Board of
Directors of Adolor Corporation (“Adolor” or the “Company”)
(NASDAQ: ADLR) breached its fiduciary duty to its shareholders in
agreeing to sell Adolor to Cubist Pharmaceuticals, Inc.
Under the terms of the agreement, Adolor shareholders will
receive $4.25 in cash for each share they own (plus a Contingent
Payment Right). The investigation is focused on the potential
unfairness of the price to Adolor shareholders and the process by
which the Adolor Board of Directors considered and approved the
transaction.
If you are interested in discussing your rights as an Adolor
shareholder and/or have information relating to the matter, please
contact U. Seth Ottensoser at (877) 779-1414 or
Ottensoser@bernlieb.com.
Bernstein Liebhard has pursued hundreds of securities, consumer
and shareholder rights cases and recovered almost $3 billion for
its clients. It has been named to The National Law Journal’s
“Plaintiffs’ Hot List” in each of the last eight years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
www.bernlieb.com
ATTORNEY ADVERTISING. © 2011 Bernstein Liebhard LLP. The law
firm responsible for this advertisement is Bernstein Liebhard LLP,
10 East 40th Street, New York, New York 10016, (212) 779-1414. The
lawyer responsible for this advertisement in the State of
Connecticut is Mary U. Hoover. Prior results do not guarantee or
predict a similar outcome with respect to any future matter.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024